VMT Scientific

VMT Scientific is a clinical-stage medical device company specializing in the development of micro-infusion technologies for vascular applications. The company's flagship product is a proprietary micro-infusion catheter designed to provide targeted, circumferential delivery of therapeutic agents into the adventitial layer of blood vessels. This approach is primarily aimed at treating Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) by enabling high local concentrations of drugs or biologics. By bypassing the endothelial barrier, the technology seeks to improve the durability of vascular interventions and patient outcomes. VMT Scientific is currently conducting clinical studies to validate the safety and performance of its delivery platform.